6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trialJoo‐Yong Hahn, Hun Sik Park, Jin‐Yong Hwang et al.|The Lancet|2018Cited by 372
Efficacy and safety of clopidogrel versus aspirin monotherapy in patients at high risk of subsequent cardiovascular event after percutaneous coronary intervention (SMART-CHOICE 3): a randomised, open-label, multicentre trialKi Hong Choi, Joo-Yong Hahn, Yong Hwan Park et al.|The Lancet|2025Cited by 86
Effectiveness and Safety of Zotarolimus-Eluting Stent (Resolute™ Integrity) in Patients with Diffuse Long Coronary Artery DiseaseKeun Ho Park, Doo‐Il Kim, Youngkeun Ahn et al.|Korean Circulation Journal|2019Cited by 23
Clinical Results of Drug-Coated Balloon Treatment in a Large-Scale Multicenter Korean Registry StudySang Yeub Lee, Doo‐Il Kim, Yun‐Kyeong Cho et al.|Korean Circulation Journal|2022Cited by 17
Duration of clopidogrel-based dual antiplatelet therapy and clinical outcomes after endeavor sprint zotarolimus-eluting stent implantation in patients presenting with acute coronary syndromePil Sang Song, Hyeon‐Cheol Gwon, Joo‐Yong Hahn et al.|European Journal of Internal Medicine|2015Cited by 7